October 18, 2011
A New York federal judge on Tuesday tossed a shareholder class action alleging biotechnology company Elan Corp. PLC failed to disclose that a proposed $1 billion deal with Johnson & Johnson violated an agreement with Biogen Idec Inc.
February 25, 2011
Elan Corp. PLC shareholders filed a class action against the company Thursday in New York, alleging it failed to disclose that a proposed $1 billion deal with Johnson & Johnson violated an agreement with Biogen Idec Inc.